Audentes, a subsidiary of Astellas Pharma, said the 135,000-square-foot plant will create 200 jobs.
The first phase of construction will take place over the next 18 months, and the facility should be operational by next year, the drugmaker said.
Pfizer, AveXis, bluebird bio and Eli Lilly all have or are also building manufacturing sites in North Carolina, according to BioPharma Dive.
Read the full news release here.
More articles on pharmacy:
Expect drug shortages by March if coronavirus continues to ravage China, expert warns
Sanofi, HHS to collaborate on coronavirus vaccine
Pharma execs blast Belcher Pharmaceuticals’ 600 percent drug price hike
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
